Anti-HRC antibody in study which defines HRC as a novel candidate oncogene involved in HCC metastasis
August, 2021 (Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
Histidine-rich calcium-binding protein (HRC) is markedly overexpressed in hepatocellular carcinoma (HCC) and is significantly correlated with metastasis.
Using our anti-HRC antibody (HPA004833), Suhong Xia et al.'s study defines HRC as a novel candidate oncogene involved in HCC metastasis and a new potential therapeutic target.
Read more: https://lnkd.in/dZaiudJ2
Explore our anti-HRC antibody available as 25 and 100 μL: https://lnkd.in/dq5RBDQZ